Overall rank by patents
#5,427
Across all tracked assignees
USPTO PatentsView assignee record - 63 granted patents across 35 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A41D (OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES).
The verdict
Ansell holds 63 US patents across 35 technology areas, rank #5,427 of 50,000 tracked assignees.
Ansell Limited has been granted 63 US utility patents between 2015 and 2025, placing Ansell Limited at rank #5,427 across all assignees tracked by PlainPatent. This portfolio spans 35 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.2 claims per patent with primary concentration in A41D (OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES). As a Foreign Corporation, Ansell Limited is one of the more focused assignees in the PatentsView dataset. By volume, Ansell sits between Abbvie Biotechnology Ltd. (63 patents, rank #5,423) and Clearpath Robotics Inc. (63 patents, rank #5,431) - the closest US assignees by grant volume. The composite Innovation Score of 47.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 24 grants, compared with 39 in the 2015–2019 window, a -38% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ansell Limited's 13.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 35 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ansell Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AbbVie Biotechnology Ltd.
63 patents
Advanced Drainage Systems, Inc.
63 patents
Affectiva, Inc.
63 patents
Agfa-Gevaert NV
63 patents
BGI SHENZHEN
63 patents
Baldwin Filters, Inc.
63 patents
Brewer Science, Inc.
63 patents
CLEARPATH ROBOTICS INC.
63 patents
Ansell Limited
63 patents
What this shows Ansell holds 63 patents at rank #5,427, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,427 in granted patent volume.
Other assignees with the most granted patents in Ansell's primary technology class.
Ansell's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 11.1% |
| 2016 | 5 | 7.9% |
| 2017 | 9 | 14.3% |
| 2018 | 9 | 14.3% |
| 2019 | 9 | 14.3% |
| 2020 | 5 | 7.9% |
| 2021 | 5 | 7.9% |
| 2022 | 3 | 4.8% |
| 2023 | 4 | 6.3% |
| 2024 | 5 | 7.9% |
| 2025 | 2 | 3.2% |
Top 15 of 35 technology areas
Overall rank by patents
#5,427
Across all tracked assignees
47.4 out of 100
How to use this portfolio
Ansell's 63 grants land it in the top 19% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.